You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dolutegravir

Showing 26 - 50 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)

Completed
  • HIV-1-infection
  • Hepatic Impairment
  • Smolensk, Russian Federation
    Regional State Budgetary Healthcare Institution "Smolensk Region
Jan 10, 2022

HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)

Active, not recruiting
  • HIV Infections
  • Los Angeles, California
  • +65 more
Jul 18, 2022

HIV-infection/Aids, Human Herpesvirus 4 Infections, Cytomegalovirus Infections Trial (NRTIs, Darunavir, Ritonavir)

Withdrawn
  • HIV-infection/Aids
  • +4 more
  • (no location specified)
Nov 8, 2020

Human Immunodeficiency Virus Trial in Rotterdam (Dolutegravir)

Completed
  • Human Immunodeficiency Virus
  • Dolutegravir
  • Rotterdam, Zuid Holland, Netherlands
    Erasmus Medical Center
Jan 27, 2020

Dolutegravir on Etonogestrel Levels in HIV-infected Botswana

Completed
  • Contraceptive Usage
  • +2 more
  • dolutegravir
  • +2 more
  • Gaborone, Botswana
    Botswana-UPenn Partnership
Feb 4, 2020

Chronic Infection, HIV Trial in Sao Paulo (Maraviroc, Dolutegravir, Dendritic Cell Vaccine)

Completed
  • Chronic Infection
  • HIV
  • Sao Paulo, SP, Brazil
    CCDI
Jul 25, 2020

HIV Infection Primary Trial (Dolutegravir)

Completed
  • HIV Infection Primary
  • Dolutegravir
  • (no location specified)
Oct 28, 2019

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir)

Completed
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Dolutegravir
  • Phoenix, Arizona
  • +73 more
Sep 28, 2020

HIV Infection Trial in United States (dolutegravir, lamivudine, Continue current antiretroviral regimen)

Completed
Has Results
  • HIV Infection
  • dolutegravir
  • +2 more
  • San Diego, California
  • +6 more
Oct 10, 2019

Infection, Human Immunodeficiency Virus Trial in Overland Park (Dolutegravir, Lamivudine, Dolutegravir + Lamivudine FDC

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • Dolutegravir
  • +3 more
  • Overland Park, Kansas
    GSK Investigational Site
Oct 10, 2018

Antiretroviral Drugs and Related Drugs During and After

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

HIV Trial in France (dolutegravir 50mg +abacavir 600mg +lamivudine 300mg, dolutegravir)

Terminated
  • HIV
  • dolutegravir 50mg +abacavir 600mg +lamivudine 300mg
  • dolutegravir
  • La Roche sur Yon, France
  • +8 more
Nov 8, 2018

Monotherapy, Dolutegravir, Primary HIV Infection Trial in Zurich (Dolutegravir, Standard of care combinational antiretroviral

Unknown status
  • Monotherapy
  • +3 more
  • Dolutegravir
  • Standard of care combinational antiretroviral therapy
  • Zurich, Switzerland
    University Hospital Zurich, University of Zurich
Oct 11, 2018

Acquired Immune Deficiency Syndrome Virus Trial in Barcelona (Dolutegravir, Darunavir/r)

Unknown status
  • Acquired Immune Deficiency Syndrome Virus
  • Barcelona, BCN, Spain
    Hospital Clinic of Barcelona
Aug 2, 2018

A Prospective, Non-interventional Study of Use of Dolutegravir

Completed
  • Infection, Human Immunodeficiency Virus
  • Dolutegravir
  • Freiburg, Baden-Wuerttemberg, Germany
  • +37 more
Aug 10, 2018

HIV Trial in Carlton, Prahran (dolutegravir, Placebo)

Completed
  • HIV
  • dolutegravir
  • Placebo
  • Carlton, Victoria, Australia
  • +1 more
Nov 16, 2017

HIV Trial in Worldwide (Dolutegravir)

Completed
  • HIV
  • Dolutegravir
  • Antwerp, Belgium
  • +32 more
Apr 6, 2018

Human Immunodeficiency Virus, Dolutegravir, Monotherapy Trial in Geneva (Dolutegravir)

Completed
  • Human Immunodeficiency Virus
  • +3 more
  • Dolutegravir
  • Geneva, Switzerland
    University Hospitals of Geneva, HIV unit
Oct 31, 2017

HIV-1 Infection Trial in Puerto Rico, United States (Dolutegravir, Lamivudine)

Completed
Has Results
  • HIV-1 Infection
  • Los Angeles, California
  • +25 more
Apr 10, 2018

HIV-1-infection, Tuberculosis Trial (Dolutegravir, Rifampicin)

Unknown status
  • HIV-1-infection
  • Tuberculosis
  • (no location specified)
Oct 20, 2017

HIV-1 Trial in Barcelona (Dolutegravir, PI, 2 NRTI)

Completed
  • HIV-1
  • Dolutegravir
  • +2 more
  • Barcelona, Spain
    Hospital Universitari Vall d'Hebron
Jun 13, 2017

Infection, Human Immunodeficiency Virus Trial in Austin (Dolutegravir, BMS955176)

Completed
  • Infection, Human Immunodeficiency Virus
  • Austin, Texas
    GSK Investigational Site
Jan 17, 2017

Infection, Human Immunodeficiency Virus I Trial in Worldwide (Dolutegravir, Atripla, Abacavir/Lamivudine)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus I
  • Dolutegravir
  • +5 more
  • Hobson City, Alabama
  • +144 more
Mar 8, 2018

HIV Trial in Badalona (Dolutegravir)

Completed
  • HIV
  • Dolutegravir
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Sep 30, 2015

Infection, Human Immunodeficiency Virus Trial in Worldwide (dolutegravir)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • dolutegravir
  • Beverly Hills, California
  • +88 more
Dec 7, 2015